Skip to main navigation Skip to search Skip to main content

Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia

  • Muhammad Mansha
  • , Michela Carlet
  • , Christian Ploner
  • , Georg Gruber
  • , Muhammad Wasim
  • , Gerrit Jan Wiegers
  • , Johannes Rainer
  • , Stephan Geley
  • , Reinhard Kofler*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Glucocorticoids (GCs) cause apoptosis and cell cycle arrest in lymphoid cells and are used in the therapy of lymphoid malignancies. SLA (Src-like-adaptor), an inhibitor of T- and B-cell receptor signaling, is a promising candidate derived from expression profiling analyses in children with acute lymphoblastic leukemia (ALL). Over-expression and knock-down experiments in ALL in vitro model revealed that transgenic SLA alone had no effect on survival or cell cycle progression, nor did it affect sensitivity to, or kinetics of, GC-induced apoptosis. Although SLA is a prominent GC response gene, it does not seem to contribute to the anti-leukemic effects of GC.

Original languageEnglish
Pages (from-to)529-534
Number of pages6
JournalLeukemia Research
Volume34
Issue number4
DOIs
StatePublished - Apr 2010
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CCRF-CEM
  • Functional gene analysis
  • Glucocorticoid-induced apoptosis
  • Lentiviral construct
  • NALM6
  • PreB697
  • Signal transduction
  • Stable transfected cell line

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Cite this